The team at Mills & Reeve LLP is noted for its ‘expert background’ and ’vast experience’ and often acts for a diverse range of pharma and diagnostic companies, research charities, and investors on fundraising matters. James Fry leads the team, and is noted for his deep knowledge of IP licensing and medicinal product promotional work. Promoted to partner in May 2024, Stephanie Caird draws on her prior in-house experience at major life sciences companies to advise on the regulatory aspects of clinical trials and research collaborations. Zickie Lim leads the firm’s venture capital and equity investments practice, utilising his longstanding experience to assist on major university spin outs.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Vast experience in dealing with similar cases, and fast and reliable advice as a result of those experiences.’
‘Expert background in given areas -such as life science, precision fermentation & food in general.’
Key clients
- GSK
- Illumina
Work highlights
Advised Illumina on its groundbreaking pilot proteomics program to analyse 50,000 UK Biobank samples in collaboration with deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
James Fry
Other key lawyers
Stephanie Caird; Zickie Lim